Lighthouse Financial’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$238K Sell
1,100
-1
-0.1% -$191 0.12% 70
2026
Q1
$202K Buy
+1,101
New +$203K 0.12% 72
2025
Q3
Sell
-1,600
Closed -$201K 76
2025
Q2
$201K Hold
1,600
0.15% 67
2025
Q1
$219K Sell
1,600
-500
-24% -$71.5K 0.19% 63
2024
Q4
$321K Buy
+2,100
New +$354K 0.26% 55

Other funds holding BIIB

Lighthouse Financial's BIIB Position: Q2 2026 in Review

Lighthouse Financial reduced its Biogen (BIIB) stake by 0.09% in Q2 2026, selling an estimated $191 and leaving 1,100 shares worth $238K. The position accounts for 0.12% of the portfolio, ranked #70.

Lighthouse Financial first reported a position in BIIB in Q4 2024 and has held it in 5 quarters since. The position peaked at $321K in Q4 2024. 1,043 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Lighthouse Financial held 1,100 shares of Biogen worth $238K as of Q2 2026.
  • Lighthouse Financial sold 1 Biogen share in Q2 2026, an estimated $191.
  • Biogen made up 0.12% of Lighthouse Financial's portfolio in Q2 2026, its #70 holding.
  • Lighthouse Financial first reported a position in Biogen in Q4 2024 and has held it in 5 quarters since.
  • Lighthouse Financial's Biogen position peaked at $321K in Q4 2024.
  • 1,043 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Lighthouse Financial's 13F filing for Q2 2026, filed 14 Aug 2026.